Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study.

Publication

Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study.

Journal Paper/Review - Feb 2, 2022

Jakeman Bernadette, Scherrer Alexandra, Battegay Manuel, Günthard Huldrych F, Hachfeld Anna, Calmy Alexandra, Schmid Patrick, Bernasconi Enos, Cavassini Matthias, Marzolini Catia

Citation

Jakeman B, Scherrer A, Battegay M, Günthard H, Hachfeld A, Calmy A, Schmid P, Bernasconi E, Cavassini M, Marzolini C. Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study. J Antimicrob Chemother 2022; 77:492-499.

Type

Journal Paper/Review (English)

Journal

J Antimicrob Chemother 2022; 77

Publication Date

Feb 2, 2022

Issn Electronic

1460-2091

Pages

492-499

Brief description/objective

Anticholinergic (ACH) medications have been associated with neurocognitive impairment, particularly in the elderly. This study determined prospectively the prevalence of prescribed ACH medications and their association with self-reported neurocognitive impairment (SRNI) in elderly people living with HIV (PLWH) of the Swiss HIV Cohort Study (SHCS).